论文部分内容阅读
目的观察阿奇霉素治疗支原体肺炎的临床疗效及不良反应。方法将56例肺炎支原体肺炎患者,随机分为两组各28例,治疗组采用阿奇霉素治疗,对照组用红霉素治疗,观察治疗前后患者症状,肺部体征的变化及不良反应。结果治疗组、对照组总有效率分别为96.4%和82.1%,两组比较差异具有统计学意义,不良反应的差异有统计学意义,治疗组明显优于对照组。结论阿奇霉素治疗支原体肺炎使用安全、简便,疗效好,值得临床推广使用。
Objective To observe the clinical efficacy and side effects of azithromycin in the treatment of mycoplasma pneumonia. Methods 56 cases of Mycoplasma pneumoniae pneumonia were randomly divided into two groups of 28 cases. The treatment group was treated with azithromycin. The control group was treated with erythromycin. The symptoms, signs of lung changes and adverse reactions before and after treatment were observed. Results The total effective rates of the treatment group and the control group were 96.4% and 82.1%, respectively. The differences between the two groups were statistically significant and the differences were statistically significant. The treatment group was significantly better than the control group. Conclusion Azithromycin safe, simple and effective in the treatment of Mycoplasma pneumonia is worthy of clinical promotion.